הלוואות ואשראי לטווח ארוך של החברה OpGen Corp (OPGN)

OpGen, Inc. (OPGN) specializes in detecting dangerous infections, yet faces the threat of delisting and a shortage of funds. Meanwhile, hospitals value OpGen, Inc. (OPGN) for its rapid genetic diagnostics that help save lives. The market trend reflects long-term debt at 0.00, confirming a systemic management crisis and the forced divestment of patents to settle obligations.

Long-term debt measures the total liabilities with a maturity of more than one year, determining the stability of the capital structure. This metric allows for an assessment of the issuer's ability to service loans without the risk of immediate default. Evaluating the long-term debt of OpGen, Inc. (OPGN) is critically important due to bankruptcy threats and the complexity of test certification. Rising borrowings coupled with low diagnostic adoption increase systemic risk. A high credit load renders the investment profile high-risk.